|
FOR
IMMEDIATE RELEASE
December
11, 2003
Guava
Technologies: CFR Part 11 Compliant Cell Culture Monitoring.
Guava
Technologies has announced that using their ViaCount assay, bioprocessing
facilities can now determine cell numbers and viability with greater
speed, accuracy and reliability than ever before while still complying
with 21 CFR Part 11 requirements.
The
Guava ViaCount assay has been demonstrated to count multiple samples
in a fraction of the time needed for manual hemacytometer cell counts
while substantially improving assay precision and greater accuracy.
The ViaCount assay also provides more accurate viability assessments
than traditional Trypan Blue-based methods since the ViaCount assay
can easily distinguish apoptotic cells from healthy live cells and
dead cells.
New
versions of Guava Technologies' CytoSoft Software, version 2.1 for
the Guava PCA system and version 2.5 for the Guava PCA-96 system,
include enhanced support for 21 CFR Part 11 compliance. To help
manage increasing volumes of data, results are automatically summarised
in spreadsheet files, which users can put directly into the laboratory
record, eliminating data transcription errors. Moreover, the Guava
CytoSoft software includes features that support compliance with
FDA 21 CFR Part 11 regulations.
A
new applications note describing strategies that customers can employ
for validating the Guava ViaCount assay and adopting the Guava PCA
into their GMP environments is now available from the Guava Technologies
website at www.guavatechnologies.com
in the online library section.
CONTACTS:
|